Workflow
RealsunChem(301212)
icon
Search documents
联盛化学(301212) - 2025 Q2 - 季度财报
2025-08-26 11:05
浙江联盛化学股份有限公司 2025 年半年度报告全文 浙江联盛化学股份有限公司 2025 年半年度报告 2025-033 2025 年 08 月 1 浙江联盛化学股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的 真实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别 和连带的法律责任。 公司负责人牟建宇、主管会计工作负责人黄清辉及会计机构负责人(会计 主管人员)黄清辉声明:保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告所涉及的未来计划、发展战略等前瞻性描述不构成公司对投资者的 实质承诺,投资者及相关人士均应当对此保持足够风险认知,并且应当理解计 划、预测与承诺之间的差异,敬请投资者注意投资风险。 公司在经营管理中可能面临的主要风险有宏观经济波动风险、原材料价格 波动风险、安全生产的风险、环保合规风险、汇率波动风险、客户集中风险、 产品价格下降的风险和政策风险等,具体详见本报告"第三节 管理层讨论与 分析"之"十、公司面临的风险和应对措施"。敬请广大投资者 ...
联盛化学(301212) - 301212联盛化学投资者关系管理信息20250611
2025-06-11 11:28
Group 1: Performance Overview - The chemical industry has shown signs of recovery compared to the past two years, with improved operational conditions in Q1 2025 and increased market demand for major products year-on-year [2][3] - The first half of the year is still ongoing, and performance results have yet to be finalized [3] Group 2: Product Development and Capacity - The production of propyl acetate is expected to reach around 800 tons in 2024, with anticipated increases in 2025 as the market for lithium battery electrolytes expands [4] - Revenue from electronic chemicals increased by 110% year-on-year in 2024, with further growth expected in 2025 due to ongoing technical upgrades and an expanding customer base [5] Group 3: Market Trends and Competition - The chemical industry is experiencing a gradual recovery in market demand, particularly as the pesticide sector approaches inventory clearance, leading to increased demand for major products [5][6] - Despite the overall increase in demand, the competitive landscape remains intense, with varying supply and demand dynamics across different products [6] Group 4: Future Plans and Financing - The company is focused on advancing its fundraising projects and has not disclosed any plans for refinancing or stock incentive programs at this time [6]
联盛化学: 浙江联盛化学股份有限公司2024年年度权益分派实施公告
Zheng Quan Zhi Xing· 2025-06-04 12:04
Group 1 - The company has approved a cash dividend distribution plan for the fiscal year 2024, with a total distribution of 12 million RMB (before tax) to shareholders [1][2] - The distribution is set at 1.20 RMB per 10 shares, based on a total share capital of 108 million shares as of April 23, 2025 [1][2] - The dividend will not include stock bonuses or capital reserve transfers, with any undistributed profits carried forward to the next fiscal year [1] Group 2 - The record date for the dividend distribution is June 11, 2025, and the ex-dividend date is June 12, 2025 [2] - The distribution will be directly credited to shareholders' accounts through their securities companies or other custodians [2] - The company assumes all legal responsibilities for any issues arising from insufficient cash dividends due to a decrease in shareholders' securities [2] Group 3 - The company has made commitments regarding the minimum selling price of shares held by shareholders after the lock-up period, which will be adjusted to not less than 28.767 RMB per share following the dividend distribution [2]
联盛化学(301212) - 浙江联盛化学股份有限公司2024年年度权益分派实施公告
2025-06-04 11:15
证券代码:301212 证券简称:联盛化学 公告编号:2025-028 浙江联盛化学股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 浙江联盛化学股份有限公司(以下简称"公司"或"本公司")2024 年年度 权益分派方案已获 2025 年 5 月 15 日召开的 2024 年年度股东大会审议通过,现 将权益分派事宜公告如下: 一、股东大会审议通过权益分派方案情况 1、公司于 2025 年 5 月 15 日召开 2024 年年度股东大会,审议通过了《关于 公司<2024 年度利润分配预案>的议案》,具体方案如下:公司以截至 2025 年 4 月 23 日的总股本 108,000,000 股为基数,向全体股东每 10 股派发现金红利 1.20 元(含税),合计派发 1,296 万元(含税)。本次利润分配不送红股,不以公积 金转增股本,剩余未分配利润结转至下一年度。 2、自权益分派方案披露之日起至实施期间,公司股本总额未发生变化。 3、本次实施的权益分派方案与 2024 年年度股东大会审议通过的权益分派方 案一致。 4、 ...
联盛化学(301212) - 301212联盛化学投资者关系管理信息20250516
2025-05-16 08:36
Group 1: Financial Performance - In 2024, the company's revenue decreased by 4.47%, and the net profit attributable to shareholders dropped significantly by 75.73% due to a larger decline in product sales prices compared to raw material prices, resulting in a substantial decrease in gross margin [3] - The company reported that the net profit decline was primarily driven by the significant drop in sales prices [3] Group 2: Research and Development - The company emphasizes R&D as a key driver for development, focusing on high-value products in electronic chemicals, specialty new materials, and pharmaceutical intermediates [3] - R&D investment as a percentage of total revenue has remained stable over the past three years [3] Group 3: Market and Product Development - The company is currently constructing new projects for ultra-pure electronic chemicals and biodegradable new materials, with specific capacity and expected revenue detailed in the 2024 annual report [4] - In the first quarter, some products saw a year-on-year increase in overseas demand, with electronic chemicals revenue increasing by over 110% [4] Group 4: Environmental Compliance - The company invested 6.73 million yuan in environmental protection and successfully passed the B-level rating for air pollution prevention and control performance [4] - The company adheres to national environmental laws and regulations, ensuring compliance with the latest environmental policies [4] Group 5: Customer Base and Market Positioning - The company's main clients include well-known large enterprises such as Bayer Group and Lawrence Research [4] - The company is focusing on differentiated competition by understanding market needs and providing customized solutions [4] Group 6: Sustainability Initiatives - The company is committed to green, low-carbon, and digital transformation, enhancing technology innovation and process optimization [5] - Efforts include energy-saving and emission-reduction actions, integrating low-carbon training into daily operations to support sustainable development [5]
联盛化学(301212) - 浙江联盛化学股份有限公司2024年年度股东大会决议公告
2025-05-15 11:28
证券代码:301212 证券简称:联盛化学 公告编号:2025-027 2024 年年度股东大会决议公告 1、召开时间:2025 年 5 月 15 日(星期四)14:30 2、召开地点:浙江省临海市头门港经济开发区东海第三大道9号公司会议室 3、召开方式:本次股东大会采用现场投票与网络投票表决相结合的方式召开 浙江联盛化学股份有限公司 4、召集人:浙江联盛化学股份有限公司(以下简称"公司")董事会 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 1、本次股东大会不存在否决议案的情形。 参加本次股东大会现场会议和网络投票表决的股东及股东代理人共 48 人, 代表有表决权的股份合计为 81,139,300 股,占公司有表决权股份总数 108,000,000 股的 75.1290%。其中:通过现场投票的股东共 5 人,代表有表决 权的公司股份数合计为 81,000,400 股,占公司有表决权股份总数 108,000,000 股的 75.0004%;通过网络投票的股东共 43 人 ...
联盛化学(301212) - 国浩律师(杭州)事务所关于浙江联盛化学股份有限公司2024年年度股东大会法律意见书
2025-05-15 11:28
国浩律师(杭州)事务所 关于 浙江联盛化学股份有限公司 2024 年年度股东大会 法律意见书 地址:杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编:310008 Grandall Building, No.2&No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail:grandallhz@grandall.com.cn 网址/Website:http://www.grandall.com.cn 二〇二五年五月 国浩律师(杭州)事务所 法律意见书 国浩律师(杭州)事务所 关于浙江联盛化学股份有限公司 2024 年年度股东大会 法律意见书 致:浙江联盛化学股份有限公司 国浩律师(杭州)事务所(以下简称"本所")接受浙江联盛化学股份有限 公司(以下简称"公司")委托,指派律师出席公司 2024 年年度股东大会(以下 简称"本次股东大会"),并依据《中华人民共和国 ...
5月13日涨停分析
news flash· 2025-05-13 07:20
5月13日涨停分析 今日共48股涨停,连板股总数11只,19股封板未遂,封板率为71%(不含ST股、退市股)。焦点股方面,军工板块成飞集成、利君股份、天箭科技均晋级5 连板,化工股红墙股份16天10板,高外销占比的华纺股份反包涨停走出6天5板。 | 股票名称 | 板数 | 涨跌幅 | 涨停时间 | 上涨逻辑 | | --- | --- | --- | --- | --- | | 宝馨科技 | 6天4板 | 9.93% | 09:42 | 机器人+光 | | 002514 | | | | 伏 | | 百达精工 | 4天3板 | 9.98% | 14:10 | 压缩机+光 | | 603331 | | | | 伏 | | 鑫磊股份 | 4天2板 | 20.00% | 14:22 | 压缩机+光 | | 301317 | | | | 伏 | | 集泰股份 | 首板 | 9.97% | 09:36 | 光伏+有机 | | 002909 | | | | 硅 | | 欧晶科技 | 首板 | 9.98% | 09:41 | 光伏+半导 | | 001269 | | | | 体 | | 泉运通 | 首板 | 10.14% | ...
联盛化学(301212) - 浙江联盛化学股份有限公司关于举办2024年度暨2025年第一季度业绩说明会的公告
2025-05-08 10:01
证券代码:301212 证券简称:联盛化学 公告编号:2025-026 浙江联盛化学股份有限公司 关于举办2024年度暨2025年第一季度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 重要内容提示: 浙江联盛化学股份有限公司(以下简称"公司")已于 2025 年 04 月 25 日 在深圳证券交易所网站(www.szse.cn)及巨潮资讯网(www.cninfo.com.cn)上披 露了《浙江联盛化学股份有限公司 2024 年年度报告》《浙江联盛化学股份有限 公司 2024 年年度报告摘要》及《浙江联盛化学股份有限公司 2025 年第一季度报 告》。为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况, 公司定于 2025 年 05 月 16 日(星期五)15:00-16:00 在"价值在线"(www.ir- online.cn)举办浙江联盛化学股份有限公司 2024 年度暨 2025 年第一季度业绩 会议召开时间:2025 年 05 月 16 日(星期五)15:00-16:00 会议召开方式:网络互动方式 会议召开地点:价值在线 ...
联盛化学(301212) - 301212联盛化学投资者关系管理信息20250508
2025-05-08 09:26
Group 1: Financial Performance - In Q1 2025, the company experienced a significant increase in revenue and net profit due to a recovery in demand within the chemical industry, with a notable rise in sales volume of key products [2] - The BDO industry chain products saw an increase in capacity utilization compared to the same period last year, reflecting improved customer order performance [3] Group 2: Product and Market Position - ABL, the company's flagship product, has a large production scale and high quality, with its production technology recognized as internationally advanced, making it the first in China to utilize liquid sodium for continuous reaction [4] - The demand for ABL is expected to rise following the expiration of the patent for the broad-spectrum fungicide, but the supply side remains competitive with low product prices [4] Group 3: Future Development and Investments - The company has over 500 million RMB in ongoing construction projects, primarily focused on ultra-pure electronic chemicals and biodegradable new materials [4] - As of December 31, 2024, the company employed 411 people and has plans for potential employee stock ownership programs in the future [4] Group 4: Industry Outlook - The fine chemical industry is a strategic focus for global chemical development, with the company emphasizing green, low-carbon, and digital transformation [5] - The company aims to enhance its position in the fine chemical sector by advancing its three main business areas: fine chemicals, electronic chemicals, and biodegradable new materials, supported by 51 invention patents as of the end of 2024 [5]